Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS)
CNY 8.62
(0.12%)
CNY 8.62
(0.12%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 449.61 Million CNY | 12.52% |
| 2022 | 393.75 Million CNY | 26.15% |
| 2021 | 312.12 Million CNY | 35.15% |
| 2020 | 230.95 Million CNY | 44.85% |
| 2019 | 159.44 Million CNY | 46.41% |
| 2018 | 108.9 Million CNY | -24.94% |
| 2017 | 145.07 Million CNY | 31.8% |
| 2016 | 110.07 Million CNY | -18.8% |
| 2015 | 135.57 Million CNY | 24.7% |
| 2014 | 108.71 Million CNY | 93.55% |
| 2013 | 56.17 Million CNY | 260.27% |
| 2012 | 15.59 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 113.22 Million CNY | -34.75% |
| 2024 Q1 | 173.53 Million CNY | 188.76% |
| 2024 Q3 | 103.77 Million CNY | -8.35% |
| 2023 Q2 | 117.24 Million CNY | -24.17% |
| 2023 Q3 | 115.5 Million CNY | -1.48% |
| 2023 FY | 443.05 Million CNY | 12.52% |
| 2023 Q1 | 154.61 Million CNY | 53.06% |
| 2023 Q4 | 60.09 Million CNY | -47.97% |
| 2022 Q4 | 101.01 Million CNY | 3.28% |
| 2022 Q2 | 80.79 Million CNY | -29.2% |
| 2022 Q1 | 114.12 Million CNY | 47.62% |
| 2022 FY | 393.75 Million CNY | 26.15% |
| 2022 Q3 | 97.81 Million CNY | 21.06% |
| 2021 Q2 | 85.14 Million CNY | 6.71% |
| 2021 FY | 312.12 Million CNY | 35.15% |
| 2021 Q1 | 79.78 Million CNY | 30.42% |
| 2021 Q4 | 77.3 Million CNY | 10.62% |
| 2021 Q3 | 69.88 Million CNY | -17.92% |
| 2020 Q3 | 52.11 Million CNY | -30.24% |
| 2020 Q2 | 74.69 Million CNY | 73.84% |
| 2020 FY | 230.95 Million CNY | 44.85% |
| 2020 Q1 | 42.96 Million CNY | -17.97% |
| 2020 Q4 | 61.17 Million CNY | 17.4% |
| 2019 Q3 | 40.76 Million CNY | 8.68% |
| 2019 Q2 | 37.5 Million CNY | 30.3% |
| 2019 Q1 | 28.78 Million CNY | -30.07% |
| 2019 FY | 159.44 Million CNY | 46.41% |
| 2019 Q4 | 52.38 Million CNY | 28.5% |
| 2018 Q1 | 22.31 Million CNY | -63.05% |
| 2018 Q3 | 16.61 Million CNY | -42.35% |
| 2018 Q2 | 28.81 Million CNY | 29.15% |
| 2018 FY | 108.9 Million CNY | -24.94% |
| 2018 Q4 | 41.16 Million CNY | 147.82% |
| 2017 FY | 145.07 Million CNY | 31.8% |
| 2017 Q3 | 27.41 Million CNY | -21.18% |
| 2017 Q2 | 34.78 Million CNY | 54.54% |
| 2017 Q1 | 22.5 Million CNY | -44.84% |
| 2017 Q4 | 60.37 Million CNY | 120.23% |
| 2016 Q1 | 24.56 Million CNY | 0.0% |
| 2016 Q3 | 24.63 Million CNY | 22.69% |
| 2016 Q2 | 20.08 Million CNY | -18.25% |
| 2016 Q4 | 40.8 Million CNY | 65.61% |
| 2016 FY | 110.07 Million CNY | -18.8% |
| 2015 FY | 135.57 Million CNY | 24.7% |
| 2015 Q1 | 22.87 Million CNY | 0.0% |
| 2014 FY | 108.71 Million CNY | 93.55% |
| 2013 FY | 56.17 Million CNY | 260.27% |
| 2012 FY | 15.59 Million CNY | 0.0% |